# Task A17: Evaluation of Therapeutic Product Candidates in Bacterial in Vitro Hollow Fiber Models

> **NIH NIH N01** · SOUTHERN RESEARCH INSTITUTE · 2021 · $462,052

## Abstract

This contract provides in vitro testing of potential anti-bacterial and anti-fungal agents, efficacy to combat the effects of toxins produced by bacteria and fungi, maintenance of bacterial, fungal and toxin stocks, and the development of related assays.

## Key facts

- **NIH application ID:** 10490547
- **Project number:** 75N93019D00014-0-759302100001-1
- **Recipient organization:** SOUTHERN RESEARCH INSTITUTE
- **Principal Investigator:** BABU TEKWANI
- **Activity code:** N01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $462,052
- **Award type:** —
- **Project period:** 2021-09-16 → 2022-08-15

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10490547

## Citation

> US National Institutes of Health, RePORTER application 10490547, Task A17: Evaluation of Therapeutic Product Candidates in Bacterial in Vitro Hollow Fiber Models (75N93019D00014-0-759302100001-1). Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/grant/nih/10490547. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*